Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Ballantyne

Circulation

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Circulation|September 26, 2001
September 11, 2001C M Ballantyne
Circulation|June 13, 2001
In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is nowG C Fonarow, C M Ballantyne
Circulation|July 1, 1994
Key references on transplant coronary artery diseaseK O Schowengerdt, C M Ballantyne
Circulation|September 15, 1996
Association of neutrophils with platelet aggregates in unstable angina. Should we alter therapy?M L Entman, C M Ballantyne
Circulation|August 1, 1993
Inflammation in acute coronary syndromesM L Entman, C M Ballantyne
Circulation|December 19, 2001
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4SC M Ballantyne, A G Olsson, T J Cook, et al.
Circulation|July 1, 1995
Cardiac allograft survival in mice deficient in intercellular adhesion molecule-1K O Schowengerdt, J Y Zhu, S M Stepkowski, et al.
Circulation|April 1, 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemiaA Hackman, Y Abe, W Insull, et al.
Circulation|September 6, 2001
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyA R Sharrett, C M Ballantyne, S A Coady, et al.
Circulation|January 7, 1998
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyS J Hwang, C M Ballantyne, A R Sharrett, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Circulation|September 26, 2001
September 11, 2001C M Ballantyne
Circulation|June 13, 2001
In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is nowG C Fonarow, C M Ballantyne
Circulation|July 1, 1994
Key references on transplant coronary artery diseaseK O Schowengerdt, C M Ballantyne
Circulation|September 15, 1996
Association of neutrophils with platelet aggregates in unstable angina. Should we alter therapy?M L Entman, C M Ballantyne
Circulation|August 1, 1993
Inflammation in acute coronary syndromesM L Entman, C M Ballantyne
Circulation|December 19, 2001
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4SC M Ballantyne, A G Olsson, T J Cook, et al.
Circulation|July 1, 1995
Cardiac allograft survival in mice deficient in intercellular adhesion molecule-1K O Schowengerdt, J Y Zhu, S M Stepkowski, et al.
Circulation|April 1, 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemiaA Hackman, Y Abe, W Insull, et al.
Circulation|September 6, 2001
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) StudyA R Sharrett, C M Ballantyne, S A Coady, et al.
Circulation|January 7, 1998
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyS J Hwang, C M Ballantyne, A R Sharrett, et al.
Pageof 2